10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q1 2012

Filing Information

Form Type	10-Q
Accession Number	`0001193125-12-049242`
Period End Date	20111231
Filing Date	20120209
Fiscal Year	2012
Fiscal Period	Q1
XBRL Instance	arwr-20111231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 102 Income Statement 84 Cash Flow Statement 131 Stockholders Equity 55

Balance Sheet 102 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.47M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.85M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.77M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.51M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1,015.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1,015.00	shares	Point-in-time
Other receivables	`OtherReceivables`	$2.03M	USD	Point-in-time
Other receivables	`OtherReceivables`	$1.61M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1,015.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$110.82K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$301.33K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1,015.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$634.59K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$71.83K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$9.17M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$9.86M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.53M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	8.64M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.53M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.64M	shares	Point-in-time
Computers, office equipment and furniture	`FurnitureAndFixturesGross`	$285.27K	USD	Point-in-time
Computers, office equipment and furniture	`FurnitureAndFixturesGross`	$502.51K	USD	Point-in-time
Research equipment	`ResearchEquipment`	$4.45M	USD	Point-in-time
Research equipment	`ResearchEquipment`	$3.52K	USD	Point-in-time
Software	`CapitalizedComputerSoftwareGross`	$105.92K	USD	Point-in-time
Software	`CapitalizedComputerSoftwareGross`	$77.02K	USD	Point-in-time
Leasehold improvements	`LeaseholdImprovementsGross`	$2.59M	USD	Point-in-time
Property, Plant and Equipment, Gross, Total	`PropertyPlantAndEquipmentGross`	$7.65M	USD	Point-in-time
Property, Plant and Equipment, Gross, Total	`PropertyPlantAndEquipmentGross`	$365.80K	USD	Point-in-time
Less: Accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$723.19K	USD	Point-in-time
Less: Accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$340.36K	USD	Point-in-time
PROPERTY AND EQUIPMENT, NET	`PropertyPlantAndEquipmentNet`	$6.93M	USD	Point-in-time
PROPERTY AND EQUIPMENT, NET	`PropertyPlantAndEquipmentNet`	$25.44K	USD	Point-in-time
Rent deposit	`DeferredRentReceivablesNetNoncurrent`	$6.26K	USD	Point-in-time
Patents and other intangible assets	`FiniteLivedIntangibleAssetsGross`	$1.73M	USD	Point-in-time
Patents and other intangible assets	`FiniteLivedIntangibleAssetsGross`	$2.75M	USD	Point-in-time
Note Receivable, net	`NotesAndLoansReceivableNetNoncurrent`	$2.31M	USD	Point-in-time
Note Receivable, net	`NotesAndLoansReceivableNetNoncurrent`	$2.27M	USD	Point-in-time
Derivative asset	`DerivativeAssetsNoncurrent`	$161.12K	USD	Point-in-time
Derivative asset	`DerivativeAssetsNoncurrent`	$160.12K	USD	Point-in-time
Investment in Nanotope Inc., equity basis	`EquityMethodInvestments`	$1.65M	USD	Point-in-time
Investment in Nanotope Inc., equity basis	`EquityMethodInvestments`	$1.54M	USD	Point-in-time
Investment in Leonardo Biosystems Inc., at cost	`CostMethodInvestments`	$187.00K	USD	Point-in-time
Investment in Leonardo Biosystems Inc., at cost	`CostMethodInvestments`	$187.00K	USD	Point-in-time
TOTAL OTHER ASSETS	`OtherAssetsNoncurrent`	$6.96M	USD	Point-in-time
TOTAL OTHER ASSETS	`OtherAssetsNoncurrent`	$6.00M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$23.06M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$15.89M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$714.06K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$576.81K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.39M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$864.51K	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$637.69K	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$195.65K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$101.04K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$1.01M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$944.98K	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$209.56K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$5.06M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$2.58M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$702.70K	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$606.79K	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$1.44M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$106.34K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$135.66K	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$742.45K	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$2.25M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 1,015 shares issued and outstanding	`PreferredStockValue`	$1.00	USD	Point-in-time
Common stock, $0.01 par value; 145,000,000 shares authorized; 10,530,524 and 8,642,286 shares issued and outstanding as of December 31, 2011 and September 30, 2011, respectively	`CommonStockValue`	$86.42K	USD	Point-in-time
Common stock, $0.01 par value; 145,000,000 shares authorized; 10,530,524 and 8,642,286 shares issued and outstanding as of December 31, 2011 and September 30, 2011, respectively	`CommonStockValue`	$105.31K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$136.32M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$127.48M	USD	Point-in-time
Subscription receivable	`ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock`	$3.90M	USD	Point-in-time
Subscription receivable	`ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock`	$900.00K	USD	Point-in-time
Accumulated deficit during the development stage	`RetainedEarningsAccumulatedDeficit`	$-116.36M	USD	Point-in-time
Accumulated deficit during the development stage	`RetainedEarningsAccumulatedDeficit`	$-113.87M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$16.17M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$12.79M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-226.94K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-420.23K	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.23M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.30M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.42M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$31.61M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.75M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.86M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.08M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.56M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.46M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$28.03M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$23.06M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$15.89M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`Revenues`	$23.96K	USD	1 Quarter
REVENUE	`Revenues`	$4.02M	USD	35 Qtrs
REVENUE	`Revenues`	$296.14K	USD	1 Quarter
Salaries	`LaborAndRelatedExpense`	$21.30M	USD	35 Qtrs
Salaries	`LaborAndRelatedExpense`	$1.32M	USD	1 Quarter
Salaries	`LaborAndRelatedExpense`	$307.89K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$26.87M	USD	35 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$631.56K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.28M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.26M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.14M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$41.57M	USD	35 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$12.59M	USD	35 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$251.88K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$370.15K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$71.62K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$60.45K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$1.85M	USD	35 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$3.63M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$4.06M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$104.18M	USD	35 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-4.04M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-3.34M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-100.17M	USD	35 Qtrs
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$48.83K	USD	1 Quarter
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-106.53K	USD	1 Quarter
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-829.78K	USD	35 Qtrs
Gain on sale of stock in subsidiary	`GainLossOnSaleOfStockInSubsidiary`	$2.29M	USD	35 Qtrs
Gain on purchase of Roche Madison	`GainOnAcquisition`	$1.58M	USD	1 Quarter
Gain on purchase of Roche Madison	`GainOnAcquisition`	$1.58M	USD	35 Qtrs
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-127.09K	USD	35 Qtrs
Realized and unrealized gain (loss) in marketable securities	`MarketableSecuritiesGainLoss`	$62.95K	USD	35 Qtrs
Realized and unrealized gain (loss) in marketable securities	`MarketableSecuritiesGainLoss`	$-58.09K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$7.88K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$15.25K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$2.72M	USD	35 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$2.83M	USD	35 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-66.90K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$465.27K	USD	1 Quarter
Other income	`OtherIncome`	$250.00K	USD	35 Qtrs
TOTAL OTHER INCOME	`NonoperatingIncomeExpense`	$529.34K	USD	1 Quarter
TOTAL OTHER INCOME	`NonoperatingIncomeExpense`	$1.35M	USD	1 Quarter
TOTAL OTHER INCOME	`NonoperatingIncomeExpense`	$8.77M	USD	35 Qtrs
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-91.39M	USD	35 Qtrs
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.69M	USD	1 Quarter
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.81M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	35 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-2.69M	USD	1 Quarter
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-2.81M	USD	1 Quarter
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-91.39M	USD	35 Qtrs
Income (loss) from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$1.57M	USD	1 Quarter
Income (loss) from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-220.00	USD	1 Quarter
Income (loss) from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-47.55M	USD	35 Qtrs
Gain on disposal of discontinued operations	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$4.71M	USD	35 Qtrs
NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-220.00	USD	1 Quarter
NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$1.57M	USD	1 Quarter
NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-42.84M	USD	35 Qtrs
NET LOSS	`ProfitLoss`	$-2.69M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-1.23M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-6.73M	USD	Annual
NET LOSS	`ProfitLoss`	$-19.96M	USD	Annual
NET LOSS	`ProfitLoss`	$-751.25K	USD	Annual
NET LOSS	`ProfitLoss`	$-6.96M	USD	Annual
NET LOSS	`ProfitLoss`	$-19.31M	USD	Annual
NET LOSS	`ProfitLoss`	$-95.24K	USD	Annual
NET LOSS	`ProfitLoss`	$-30.71M	USD	Annual
NET LOSS	`ProfitLoss`	$-134.23M	USD	35 Qtrs
NET LOSS	`ProfitLoss`	$-3.49M	USD	Annual
NET LOSS	`ProfitLoss`	$-27.24M	USD	Annual
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$206.25K	USD	1 Quarter
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-18.04M	USD	35 Qtrs
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-201.29K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-1.44M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-116.19M	USD	35 Qtrs
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-2.49M	USD	1 Quarter
Loss from continuing operations attributable to Arrowhead common shareholders	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.25	USD	1 Quarter
Loss from continuing operations attributable to Arrowhead common shareholders	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.42	USD	1 Quarter
Income from discontinued operations attributable to Arrowhead common shareholders	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$0.22	USD	1 Quarter
Net loss attributable to Arrowhead shareholders	`IncomeLossFromOperationsBeforeExtraordinaryItemsPerBasicAndDilutedShare`	$-0.25	USD	1 Quarter
Net loss attributable to Arrowhead shareholders	`IncomeLossFromOperationsBeforeExtraordinaryItemsPerBasicAndDilutedShare`	$-0.20	USD	1 Quarter
Weighted average shares outstanding-basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.18M	shares	1 Quarter
Weighted average shares outstanding-basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	10.12M	shares	1 Quarter

Cash Flow Statement 131 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-2.69M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-1.23M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-6.73M	USD	Annual
Net income (loss)	`ProfitLoss`	$-19.96M	USD	Annual
Net income (loss)	`ProfitLoss`	$-751.25K	USD	Annual
Net income (loss)	`ProfitLoss`	$-6.96M	USD	Annual
Net income (loss)	`ProfitLoss`	$-19.31M	USD	Annual
Net income (loss)	`ProfitLoss`	$-95.24K	USD	Annual
Net income (loss)	`ProfitLoss`	$-30.71M	USD	Annual
Net income (loss)	`ProfitLoss`	$-134.23M	USD	35 Qtrs
Net income (loss)	`ProfitLoss`	$-3.49M	USD	Annual
Net income (loss)	`ProfitLoss`	$-27.24M	USD	Annual
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$206.25K	USD	1 Quarter
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-18.04M	USD	35 Qtrs
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-201.29K	USD	1 Quarter
Net loss attributable to Arrowhead	`NetIncomeLoss`	$-1.44M	USD	1 Quarter
Net loss attributable to Arrowhead	`NetIncomeLoss`	$-116.19M	USD	35 Qtrs
Net loss attributable to Arrowhead	`NetIncomeLoss`	$-2.49M	USD	1 Quarter
(Income) loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$1.57M	USD	1 Quarter
(Income) loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-42.84M	USD	35 Qtrs
(Income) loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-220.00	USD	1 Quarter
Realized and unrealized (gain) loss on investments	`GainLossOnSaleOfInvestments`	$-58.09K	USD	1 Quarter
Realized and unrealized (gain) loss on investments	`GainLossOnSaleOfInvestments`	$762.95K	USD	35 Qtrs
(Gain) loss from sale of subsidiary	`GainLossFromSaleOfSubsidiary`	$306.34K	USD	35 Qtrs
(Gain) loss on purchase of Roche Madison	`GainOnAcquisition`	$1.58M	USD	1 Quarter
(Gain) loss on purchase of Roche Madison	`GainOnAcquisition`	$1.58M	USD	35 Qtrs
Loss on sale/donation of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-127.09K	USD	35 Qtrs
Stock issued as gift	`StockIssuedAsGift`	$298.75K	USD	35 Qtrs
Stock issued for professional services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$442.88K	USD	35 Qtrs
Stock issued for in-process research and development	`StockIssuedForInProcessResearchAndDevelopment`	$13.17M	USD	35 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$2.83M	USD	35 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-66.90K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$465.27K	USD	1 Quarter
Purchased in-process research and development - Nanoconduction	`ResearchAndDevelopmentInProcess`	$2.69M	USD	35 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$12.59M	USD	35 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$251.88K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$370.15K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$454.44K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$6.11M	USD	35 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$68.76K	USD	1 Quarter
Amortization (accretion) of note discounts, net	`AmortizationOfDebtDiscountPremium`	$-4.16K	USD	35 Qtrs
Amortization (accretion) of note discounts, net	`AmortizationOfDebtDiscountPremium`	$3.78K	USD	1 Quarter
Common stock, shares issued	`CommonStockSharesIssued`	10.53M	shares	Point-in-time
Gain on sale of stock in subsidiary	`GainLossOnSaleOfStockInSubsidiary`	$2.29M	USD	35 Qtrs
Common stock, shares issued	`CommonStockSharesIssued`	8.64M	shares	Point-in-time
Equity in income (loss) of unconsolidated affiliates	`GainLossOnSaleOfEquityInvestments`	$-829.78K	USD	35 Qtrs
Equity in income (loss) of unconsolidated affiliates	`GainLossOnSaleOfEquityInvestments`	$48.83K	USD	1 Quarter
Common stock value	`CommonStockValue`	$86.42K	USD	Point-in-time
Equity in income (loss) of unconsolidated affiliates	`GainLossOnSaleOfEquityInvestments`	$-106.53K	USD	1 Quarter
Common stock value	`CommonStockValue`	$105.31K	USD	Point-in-time
Noncontrolling interest	`NoncontrollingInterest`	$18.04M	USD	35 Qtrs
Noncontrolling interest	`NoncontrollingInterest`	$201.29K	USD	1 Quarter
Noncontrolling interest	`NoncontrollingInterest`	$-206.25K	USD	1 Quarter
Gain on renegotiation of accrued severance	`GainOnRenegotiationOfAccruedSeverance`	$726.50K	USD	35 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$-109.42K	USD	35 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$-172.23K	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	$419.24K	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-86.42K	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	$2.02M	USD	35 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$172.64K	USD	35 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$30.07K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-4.08K	USD	1 Quarter
Warrants exercised	`WarrantsExercised`	24,788.00	shares	Point-in-time
Stock issued against warrants	`StockIssuedAgainstWarrants`	12,870.00	shares	Point-in-time
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$96.36K	USD	35 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.00	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-96.36K	USD	1 Quarter
Deposits	`IncreaseDecreaseInDeposits`	$-36.80K	USD	35 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$137.45K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.85M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$343.88K	USD	35 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$408.78K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-20.86K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$943.32K	USD	35 Qtrs
Accrued severance and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$346.55K	USD	1 Quarter
Accrued severance and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.32M	USD	35 Qtrs
Accrued severance and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-16.01K	USD	1 Quarter
NET CASH USED IN OPERATING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-63.24M	USD	35 Qtrs
NET CASH USED IN OPERATING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-879.30K	USD	1 Quarter
NET CASH USED IN OPERATING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.71M	USD	1 Quarter
Purchase of marketable securities - US Treasury Bills	`PaymentsToAcquireMarketableSecurities`	$18.58M	USD	35 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$69.42K	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.64M	USD	35 Qtrs
Purchase of MASA Energy, LLC	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$250.00K	USD	35 Qtrs
Minority equity investment	`PaymentsToAcquireAdditionalInterestInSubsidiaries`	$2.00M	USD	35 Qtrs
Cash paid for interest in Insert	`PaymentsToAcquireInterestInSubsidiariesAndAffiliates`	$10.15M	USD	35 Qtrs
Cash obtained from interest in Insert	`ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates`	$10.53M	USD	35 Qtrs
Proceeds from sale of marketable securities - US Treasury Bills	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$18.89M	USD	35 Qtrs
Proceeds from sale of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$3.31M	USD	35 Qtrs
Proceeds from sale of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$509.01K	USD	1 Quarter
Proceeds from sale of subsidiaries	`ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries`	$359.38K	USD	35 Qtrs
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$142.38K	USD	35 Qtrs
Payment for patents	`PaymentsToAcquireIntangibleAssets`	$303.44K	USD	35 Qtrs
Restricted cash	`IncreaseDecreaseInRestrictedCash`	$-50.77K	USD	35 Qtrs
Cash transferred in acquisition/divestitures	`CashDivestedFromDeconsolidation`	$-100.03K	USD	1 Quarter
Cash transferred in acquisition/divestitures	`CashDivestedFromDeconsolidation`	$1.60M	USD	35 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-3.23M	USD	35 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$539.62K	USD	1 Quarter
Principal payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$39.94K	USD	35 Qtrs
Principal payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$39.94K	USD	1 Quarter
Proceeds from issuance of Calando debt	`ProceedsFromIssuanceOfLongTermDebt`	$2.52M	USD	35 Qtrs
Proceeds from sale of stock in subsidiary	`ProceedsFromSaleOfStockInSubsidiary`	$8.00K	USD	1 Quarter
Proceeds from sale of stock in subsidiary	`ProceedsFromSaleOfStockInSubsidiary`	$20.90M	USD	35 Qtrs
Proceeds from issuance of common stock and warrants, net	`ProceedsFromIssuanceOfCommonStock`	$43.28K	USD	1 Quarter
Proceeds from issuance of common stock and warrants, net	`ProceedsFromIssuanceOfCommonStock`	$1.46M	USD	1 Quarter
Proceeds from issuance of common stock and warrants, net	`ProceedsFromIssuanceOfCommonStock`	$96.76M	USD	35 Qtrs
NET CASH PROVIDED BY FINANCING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$43.28K	USD	1 Quarter
NET CASH PROVIDED BY FINANCING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$120.14M	USD	35 Qtrs
NET CASH PROVIDED BY FINANCING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.43M	USD	1 Quarter
Operating cash flows	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-46.00M	USD	35 Qtrs
Operating cash flows	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-420.00	USD	1 Quarter
Operating cash flows	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-544.34K	USD	1 Quarter
Investing cash flows	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$790.62K	USD	35 Qtrs
Financing cash flows	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	$-1.68M	USD	35 Qtrs
Net cash provided by (used in) discontinued operations:	`NetCashProvidedByUsedInDiscontinuedOperations`	$-420.00	USD	1 Quarter
Net cash provided by (used in) discontinued operations:	`NetCashProvidedByUsedInDiscontinuedOperations`	$-46.89M	USD	35 Qtrs
Net cash provided by (used in) discontinued operations:	`NetCashProvidedByUsedInDiscontinuedOperations`	$-544.34K	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$6.77M	USD	35 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.38M	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-734.26K	USD	1 Quarter
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$5.47M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.85M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.77M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$7.51M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$5.47M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.85M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.77M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$7.51M	USD	Point-in-time
Interest paid	`InterestPaid`	$10.30K	USD	1 Quarter
Interest paid	`InterestPaid`	$240.72K	USD	35 Qtrs
Taxes paid	`IncomeTaxesPaid`	$742.50K	USD	35 Qtrs

Stockholders Equity 55 line items

Line Item	Tag	Value	Unit	Period
Stock issued during period, value, new issues	`StockIssuedDuringPeriodValueNewIssues`	$525.00K	USD	1 Quarter
Stock issued during period, value, new issues	`StockIssuedDuringPeriodValueNewIssues`	$50.00K	USD	Annual
Stock issued during period, value, new issues	`StockIssuedDuringPeriodValueNewIssues`	$-150.47K	USD	Annual
Stock issued during period, value, new issues	`StockIssuedDuringPeriodValueNewIssues`	$1.07M	USD	Annual
Stock issued during period, value, new issues	`StockIssuedDuringPeriodValueNewIssues`	$43.28K	USD	Annual
Reclassification of former Unidym mezzanine debt to equity	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt`	$2.00M	USD	Annual
Stock issuance cost charged to additional paid-in capital	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$991.32K	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-2.69M	USD	1 Quarter
Net loss attributable to Arrowhead	`ProfitLoss`	$-1.23M	USD	1 Quarter
Net loss attributable to Arrowhead	`ProfitLoss`	$-6.73M	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-19.96M	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-751.25K	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-6.96M	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-19.31M	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-95.24K	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-30.71M	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-134.23M	USD	35 Qtrs
Net loss attributable to Arrowhead	`ProfitLoss`	$-3.49M	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-27.24M	USD	Annual
Stock issued during period, value, stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$13.88K	USD	Annual
Stock issued during period, value, stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$15.00K	USD	Annual
Stock issued during period, value, stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$23.83K	USD	1 Quarter
Stock issued during period, value, stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$434.73K	USD	Annual
Stock issued during period, value, stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$341.54K	USD	Annual
Stock issued during period, value, stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$7.63K	USD	Annual
Stock issued during period, value, stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$290.03K	USD	Annual
Adjustments to additional paid in capital, share-based compensation, requisite service period recognition, value	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$508.51K	USD	Annual
Adjustments to additional paid in capital, share-based compensation, requisite service period recognition, value	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.19M	USD	Annual
Adjustments to additional paid in capital, share-based compensation, requisite service period recognition, value	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.18M	USD	Annual
Adjustments to additional paid in capital, share-based compensation, requisite service period recognition, value	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.68M	USD	Annual
Adjustments to additional paid in capital, share-based compensation, requisite service period recognition, value	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.37M	USD	Annual
Adjustments to additional paid in capital, share-based compensation, requisite service period recognition, value	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$175.65K	USD	Annual
Adjustments to additional paid in capital, share-based compensation, requisite service period recognition, value	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$251.88K	USD	1 Quarter
Adjustments to additional paid in capital, share-based compensation, requisite service period recognition, value	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.40M	USD	Annual
Adjustments to additional paid in capital, share-based compensation, requisite service period recognition, value	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.58M	USD	Annual
Adjustments to additional paid in capital, reallocation of noncontrolling interest	`AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest`	$230.09K	USD	Annual
Adjustments to additional paid in capital, reallocation of noncontrolling interest	`AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest`	$16.30K	USD	Annual
Adjustments to additional paid in capital, reallocation of noncontrolling interest	`AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest`	$1.72M	USD	Annual
Adjustments to additional paid in capital, reallocation of noncontrolling interest	`AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest`	$300.00K	USD	Annual
Issuance of preferred stock in subsidiary	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$1.62M	USD	Annual
Issuance of preferred stock in subsidiary	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$300.00K	USD	Annual
Divestiture of Unidym	`MinorityInterestIncreaseFromStockIssuance`	$254.28K	USD	Annual
Net loss attributable to Arrowhead	`NetIncomeLoss`	$-1.44M	USD	1 Quarter
Net loss attributable to Arrowhead	`NetIncomeLoss`	$-116.19M	USD	35 Qtrs
Net loss attributable to Arrowhead	`NetIncomeLoss`	$-2.49M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.23M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.30M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.42M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$31.61M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.75M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.86M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.08M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.56M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.46M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$28.03M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.